Omzo vs Embbody: Clinician-Guided Care vs Low-Cost Compounds
Quick verdict: Omzo emphasizes clinician-guided, personalized compounded semaglutide and tirzepatide care starting at $179 with licensed provider review, while Embody emphasizes a low entry price for compounded semaglutide at $69/month and fast free 1-2 day shipping. This piece compares Omzo vs Embody across price, medication type and regulatory notes, clinical oversight, shipping and features so you can pick based on the facts supplied.
Explore Omzo clinician-guided plans
Price and pricing model compared
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279, described as personalized compounded options. Embody lists compounded semaglutide at $69/month, reduced from $299, and compounded tirzepatide at $119/month with flat monthly pricing. Embody highlights no long-term membership and a cancel anytime policy. Final pricing for both may vary based on clinician recommendation and dose.
See Omzo starting prices and options
Medication type and regulatory notes
Both platforms offer compounded GLP-1 medications. Omzo describes a Compounded Medication Program where compounded drugs are prepared by a state-licensed sterile compounding pharmacy and explicitly states these compounded drugs are not FDA-approved. Embody also states its compounded medications are not FDA-approved finished products but use the same active ingredients as branded options. Omzo notes providers may instead prescribe branded medications, in which case the patient fills them at a pharmacy and assumes costs.
Clinical oversight and prescribing differences
Omzo positions its service as clinician-guided plans reviewed by licensed U.S. providers and notes clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make final prescribing decisions. Embody describes doctor-prescribed GLP-1 treatment with prescription and telemed visits included and licensed provider review handled online. Both emphasize licensed provider review, but Omzo frames its plans as clinician-guided with provider networks while Embody emphasizes a straightforward, prescription-forward model with included telemed visits.
Visit Embody for $69/month semaglutide
Shipping speed, delivery and commitments
Omzo notes fast, discreet delivery and that medication costs are included in fees collected by Omzo, with shipment details subject to pharmacy capacity and state regulations. Embody promises free shipping with delivery in 1-2 days after clinician approval and highlights in-stock supply with flat locked monthly pricing. Embody explicitly advertises faster delivery timelines of 1-2 days.
Check Embody shipping and delivery
Distinctive differences at a glance
| Criteria | Omzo | Embody |
|---|---|---|
| Starting price | $179 semaglutide; $279 tirzepatide | $69/month semaglutide; $119/month tirzepatide |
| Medication type | Compounded plus option for prescriptions for branded meds | Compounded only; no branded dispensing |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved finished products |
| Clinical model | Clinician-guided plans reviewed by licensed U.S. providers | Licensed provider review with included telemed visits |
| Delivery speed | Fast, discreet delivery; timing may vary by pharmacy | Free shipping; arrives in 1-2 days after approval |
What each platform is best for
Omzo is presented as a clinician-guided platform that connects patients with licensed U.S. providers, offers both compounded medication programs and the possibility of prescriptions for branded medications, and discloses that compounded drugs are not FDA-approved. Embody is presented as a low-cost, prescription-forward telehealth option with $69/month semaglutide pricing, free 1-2 day shipping, no membership commitment, and simpler, flat monthly pricing.
Choose Omzo if…
You want clinician-guided plans reviewed by licensed U.S. providers, access to both compounded programs and the option that a provider may prescribe a branded medication you fill at a pharmacy, and you accept that compounded medications are not FDA-approved.
Choose Embody if…
You prioritize the lowest entry price and fast free shipping with a flat monthly model, want a prescription-forward telemed experience with included visits, and accept that Embody provides compounded GLP-1 medications that are not FDA-approved finished products.
Omzo vs Embody: both offer clinician review and compounded GLP-1 options; pick based on whether you value clinician-guided personalization and branded-prescription options with Omzo or the lower monthly price and 1-2 day shipping with Embody.